Overview
Clover Held its 2017 Board Meeting in Chengdu
2017-11-01

CHENGDU, CHINA – 01 November 2017 – Clover held its 2017 year-end board meeting in Chengdu.  Together, Clover’s Board of Directors reviewed the tremendous progress made by Clover over the past year and mapped the direction for future corporate and drug development at the company.



上一篇:SCB-313 Preclinical Data Published in Scientific Reports
下一篇:Clover Biopharmaceuticals Completes RMB 62.8 Million Series A Financing